Some adenocarcinomas develop following the mutational activation of β-catenin (CTNNB1), regulated by APC, or through an alternative pathway involving the inactivation of tumor suppressor genes responsible for DNA repair. The gene discussed is APC; the disease is adenocarcinoma.